Deutsche Bank started coverage on shares of UnitedHealth Group (NYSE:UNH) in a research report report published on Thursday, BenzingaRatingsTable reports. The firm issued a hold rating and a $263.00 price target on the healthcare conglomerate’s stock.
A number of other research firms also recently issued reports on UNH. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an overweight rating in a research report on Friday, July 12th. Cleveland Research restated a buy rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Zacks Investment Research upgraded shares of UnitedHealth Group from a sell rating to a buy rating and set a $269.00 target price for the company in a research report on Monday, July 22nd. Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the company a buy rating in a research report on Friday, July 19th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a hold rating to a sell rating in a research report on Thursday, September 5th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eighteen have given a buy rating to the stock. UnitedHealth Group presently has an average rating of Buy and an average price target of $292.47.
NYSE UNH traded up $3.51 on Thursday, reaching $233.61. 4,491,181 shares of the company’s stock traded hands, compared to its average volume of 3,573,297. The firm has a market cap of $220.30 billion, a price-to-earnings ratio of 18.14, a P/E/G ratio of 1.24 and a beta of 0.62. The stock has a 50 day moving average price of $241.01 and a 200-day moving average price of $243.65. UnitedHealth Group has a fifty-two week low of $208.07 and a fifty-two week high of $287.94. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a $1.08 dividend. The ex-dividend date of this dividend is Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.85%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
In other news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the completion of the sale, the director now owns 187,979 shares of the company’s stock, valued at $46,318,025.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the sale, the director now directly owns 61,309 shares of the company’s stock, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. In the last quarter, insiders sold 19,000 shares of company stock valued at $4,758,720. Insiders own 0.87% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Eastern Bank increased its stake in shares of UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after purchasing an additional 1,375 shares in the last quarter. Enterprise Bank & Trust Co purchased a new stake in UnitedHealth Group during the 1st quarter valued at about $3,785,000. Private Advisors LLC grew its stake in UnitedHealth Group by 57.9% during the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock valued at $1,607,000 after acquiring an additional 2,385 shares in the last quarter. Capital Investment Advisors LLC grew its stake in UnitedHealth Group by 26.2% during the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after acquiring an additional 1,323 shares in the last quarter. Finally, Berkeley Capital Partners LLC grew its stake in UnitedHealth Group by 7.4% during the 2nd quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock valued at $542,000 after acquiring an additional 153 shares in the last quarter. 86.04% of the stock is owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Capital gains and your 401(k) or IRA
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.